DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandell Asset Management Corp. | 185,000 | $39,836,000 | 22.30% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 265,810 | $57,247,000 | 14.87% |
| Eos Focused Equity Management, L.P. | 53,908 | $11,608,000 | 12.43% |
| Defender Capital, LLC. | 106,793 | $22,996,000 | 11.32% |
| Mirova US LLC | 707,129 | $152,266,000 | 8.71% |
| Riverstone Advisors, LLC | 60,706 | $13,072,000 | 8.69% |
| Front Street Capital Management, Inc. | 130,171 | $28,030,000 | 7.83% |
| MIROVA | 197,237 | $42,471,000 | 6.84% |
| Lincoln Capital LLC | 85,170 | $18,340,000 | 6.72% |
| Third Point | 3,000,000 | $645,990,000 | 6.46% |
| Pactiv General Employee Benefit Trust | 667,810 | $143,800,000 | 6.40% |
| TRAN CAPITAL MANAGEMENT, L.P. | 273,557 | $58,905,000 | 6.34% |
| AGF Investments America Inc. | 90,118 | $19,405,000 | 5.81% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 321,584 | $69,247,000 | 5.68% |
| CORTLAND ASSOCIATES INC/MO | 193,785 | $41,728,000 | 5.60% |
| Mendel Money Management | 33,146 | $7,137,000 | 5.58% |
| SANDLER CAPITAL MANAGEMENT | 256,752 | $55,286,000 | 5.56% |
| BANYAN CAPITAL MANAGEMENT, INC. | 30,411 | $6,548,000 | 5.46% |
| KELLY LAWRENCE W & ASSOCIATES INC/CA | 81,998 | $17,657,000 | 5.26% |
| DAVIS-REA LTD. | 35,903 | $7,737,000 | 5.19% |
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists DANAHER CORPORATION's shareholders in Q3 2020. To view DANAHER CORPORATION's shareholder history, click here.